HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Carmen Ortiz Mellet Selected Research

5- N,6- O- (N''- octyliminomethylidene)nojirimycin

6/2011Cyclodextrin-mediated crystallization of acid β-glucosidase in complex with amphiphilic bicyclic nojirimycin analogues.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Carmen Ortiz Mellet Research Topics

Disease

13Gaucher Disease (Gaucher's Disease)
01/2017 - 11/2009
4Neoplasms (Cancer)
12/2021 - 02/2010
3Inflammation (Inflammations)
12/2021 - 05/2010
3Breast Neoplasms (Breast Cancer)
01/2020 - 08/2010
3Infections
11/2019 - 02/2010
2Glioblastoma (Glioblastoma Multiforme)
12/2020 - 01/2017
2Mucopolysaccharidosis IV (Morquio Syndrome)
05/2014 - 03/2013
2GM1 Gangliosidosis (Gangliosidosis GM1)
05/2014 - 03/2013
1Tay-Sachs Disease
12/2022
1Leishmaniasis
12/2021
1Diabetic Retinopathy (Retinopathy, Diabetic)
01/2021
1Gliosis
01/2021
1Carcinoma (Carcinomatosis)
01/2020
1Neurodegenerative Diseases (Neurodegenerative Disease)
11/2019
1Conjoined Twins (Siamese Twins)
07/2019
1Rare Diseases (Rare Disease)
07/2019
1Mannosidase Deficiency Diseases (Mannosidosis)
01/2019
1Prostatic Neoplasms (Prostate Cancer)
01/2017
1Fabry Disease (Fabry's Disease)
09/2015
1Neurologic Manifestations (Neurological Manifestations)
06/2015
1Mitochondrial Diseases (Mitochondrial Disease)
06/2015
1Human Influenza (Influenza)
01/2015
1Pathologic Processes
01/2015
1Autoimmune Diseases (Autoimmune Disease)
11/2014
1Adenocarcinoma
11/2013
1Teratoma (Teratoid Tumor)
02/2013
1Edema (Dropsy)
01/2011
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
05/2010
1Colitis
05/2010
1Metabolic Diseases (Metabolic Disease)
02/2010
1Dehydration (Water Stress)
02/2010

Drug/Important Bio-Agent (IBA)

9Glucosylceramidase (Glucocerebrosidase)IBA
01/2017 - 11/2009
6GlucosidasesIBA
12/2014 - 11/2010
5EnzymesIBA
12/2022 - 06/2011
4GlycolipidsIBA
01/2021 - 11/2014
4CyclodextrinsIBA
12/2020 - 04/2014
4AcidsIBA
04/2014 - 11/2010
3GalactosidasesIBA
09/2015 - 03/2013
2AntigensIBA
01/2020 - 01/2011
2DNA (Deoxyribonucleic Acid)IBA
07/2019 - 11/2013
2Surface-Active Agents (Surfactants)IBA
07/2019 - 01/2017
2GlycosidesIBA
01/2015 - 08/2012
2OligosaccharidesIBA
01/2015 - 02/2010
2Glucosylceramides (Glucocerebrosides)IBA
04/2014 - 06/2011
2Proteins (Proteins, Gene)FDA Link
06/2011 - 11/2009
2FructoseIBA
05/2010 - 02/2010
1Hexosaminidase A (Hex A)IBA
12/2022
1Hexosaminidases (Hexosaminidase)IBA
12/2022
1NitrogenIBA
12/2021
1LipidsIBA
12/2021
1SulfurIBA
12/2021
1SeleniumIBA
12/2021
1sulfoxideIBA
01/2021
1Retinaldehyde (Retinal)IBA
01/2021
1Small Interfering RNA (siRNA)IBA
12/2020
1Tn antigenIBA
01/2020
1Biomarkers (Surrogate Marker)IBA
01/2020
1AutoantibodiesIBA
01/2020
1GlycopeptidesIBA
01/2020
1AntibodiesIBA
01/2020
1Mucin-1 (CA 15-3 Antigen)IBA
01/2020
1KRN 7000 (KRN7000)IBA
11/2019
1Galactosylceramides (Galactocerebrosides)IBA
11/2019
1TrehaloseIBA
07/2019
1Tyr sulfate(1)- enkephalinamide-Leu (LETS)IBA
07/2019
1DisaccharidesIBA
07/2019
1Toll-Like Receptors (Toll-Like Receptor)IBA
05/2019
11- dodecylsulfonyl- 5N,6O- oxomethylidenenojirimycinIBA
05/2019
1LipopolysaccharidesIBA
05/2019
1MannosidesIBA
05/2019
1Interleukin-6 (Interleukin 6)IBA
05/2019
1Toll-Like Receptor 4IBA
05/2019
1MannosidasesIBA
01/2019
1alpha-Mannosidase (LAMAN)IBA
01/2019
1NucleotidesIBA
01/2017
1Calixarenes (Calixarene)IBA
01/2017
1Docetaxel (Taxotere)FDA Link
01/2017
1CholesterolIBA
10/2016
1coenzyme Q10 (CoQ10)IBA
06/2015
1Reactive Oxygen Species (Oxygen Radicals)IBA
06/2015
1Ambroxol (Mucosolvan)IBA
01/2015
1Pharmaceutical PreparationsIBA
01/2015
1Mannose (D-Mannose)IBA
01/2015
1Biological ProductsIBA
01/2015
1Folic Acid (Vitamin M)FDA LinkGeneric
11/2013
1LigandsIBA
03/2013
1migalastatIBA
03/2013
15N,6S- (N'- butyliminomethylidene)- 6- thio- 1- deoxygalactonojirimycinIBA
03/2013
1SphingolipidsIBA
02/2013
1nojirimycinIBA
06/2011
15- N,6- O- (N''- octyliminomethylidene)nojirimycinIBA
06/2011
1anthrax toxin (anthrax lethal factor)IBA
01/2011
1castanospermineIBA
08/2010
1alpha-Glucosidases (Acid Maltase)IBA
08/2010
1Glycoproteins (Glycoprotein)IBA
08/2010
1Trinitrobenzenesulfonic AcidIBA
05/2010
1Sucrose (Saccharose)IBA
05/2010

Therapy/Procedure

4Therapeutics
11/2019 - 06/2011
1Enzyme Replacement Therapy
06/2015
1Oral Administration
03/2013